(PR-inside.com) TORONTO, ONTARIO -- (Marketwire) -- 12/19/11 -- Gemoscan Canada, Inc. ("Gemoscan" or the "Corporation") (CNSX:GES) (MUN:1GE) announces, subject to regulatory approval, that its Board of Directors has approved, effective December 19, 2011, the grant of an aggregate of 150,000 stock options (the "Options") to a director (50,000), and a consultant (100,000) of the Corporation. The Options are exercisable into Class A shares of Gemoscan at an exercise price of $0.35 per share. The Options all vest immediately and have a five year term to expiry. ABOUT GEMOSCAN Founded in 2003 Gemoscan owns and markets the HEMOCODE(TM) Food Intolerance ..
More...
More...